Plasticity and maintenance of hematopoietic stem cells during development

Recent Patents on Biotechnology

Volumn 5, Issue 1, 2011, Pages 40-53

  Kanji, Suman ^a   Pompili, Vincent J ^a   Das, Hiranmoy ^a  

^a OHIO STATE UNIVERSITY   (United States)

Author keywords

Clinical application; Differentiation; Embryonic development; Hematopoietic stem cells; Patents; Regulation; Self renewal; Transdifferentiation

Indexed keywords

PATENTS AND INVENTIONS; STEM CELLS;

CELL TYPES; CLINICAL APPLICATION; CONDITION; DIFFERENTIATION; EMBRYONIC DEVELOPMENT; HAEMATOPOIETIC STEM CELLS; PATENT; REGULATION; SELF RENEWAL; TRANSDIFFERENTIATION;

CYTOLOGY;

NOTCH1 RECEPTOR; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR GATA 2;

ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; CELL DIFFERENTIATION; CELL MATURATION; CELL POPULATION; CELL RENEWAL; EMBRYO DEVELOPMENT; FETUS CELL; GENE OVEREXPRESSION; GENETIC REGULATION; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL; HUMAN; INTRACELLULAR SIGNALING; MICROENVIRONMENT; NONHUMAN; ONTOGENY; PATENT; PLASTICITY; PRIORITY JOURNAL; REVIEW; STEM CELL EXPANSION;

MAMMALIA;

EID: 79956220042     PISSN: 18722083     EISSN: 18722083     Source Type: Journal    
DOI: 10.2174/187220811795655896     Document Type: Review

References (208)

1. Weissman IL. Stem cells: units of development, units of regenera-tion, and units in evolution. Cell 2000;100:157-68.
2. Wilson A, Trumpp A. Bone-marrow haematopoietic-stem-cellniches. Nat Rev Immunol 2006;6:93-106.
3. Ciau-Uitz A, Walmsley M, Patient R. Distinct origins of adult andembryonic blood in Xenopus. Cell 2000;102:787-96.
4. Traver D, Zon LI. Walking the walk: migration and other commonthemes in blood and vascular development. Cell 2002;108:731-4.
5. Tavian M, Peault B. Embryonic development of the human hema-topoietic system. Int J Dev Biol 2005;49:243-50.
6. Tavian M, Peault B. Analysis of hematopoietic development duringhuman embryonic ontogenesis. Methods Mol Med 2005;105:413-24.
7. Tavian M, Peault B. The changing cellular environments of hema-topoiesis in human development in utero. Exp Hematol 2005;33:1062-9.
8. Sabin F. Studies on the origin of blood vessel and red blood cor-puscles as seen in the living blastoderm of chicks during the secondday of incubation. Contrib Embryol 1920;9:214.
9. Medvinsky A, Dzierzak E. Definitive hematopoiesis is autono-mously initiated by the AGM region. Cell 1996;86:897-906.
10. Muller AM, Medvinsky A, Strouboulis J, Grosveld F, Dzierzak E. Development of hematopoietic stem cell activity in the mouse em-bryo. Immunity 1994;1:291-301.
11. de Bruijn MF, Speck NA, Peeters MC, Dzierzak E. Definitivehematopoietic stem cells first develop within the major arterial re-gions of the mouse embryo. Embo J 2000;19:2465-74.
12. Taoudi S, Medvinsky A. Functional identification of the hema-topoietic stem cell niche in the ventral domain of the embryonicdorsal aorta. Proc Natl Acad Sci U S A 2007;104:9399-403.
13. North TE, de Bruijn MF, Stacy T, Talebian L, Lind E, Robin C, etal. Runx1 expression marks long-term repopulating hematopoieticstem cells in the midgestation mouse embryo. Immunity 2002;16:661-72.
14. de Bruijn MF, Ma X, Robin C, Ottersbach K, Sanchez MJ, Dzier-zak E. Hematopoietic stem cells localize to the endothelial celllayer in the midgestation mouse aorta. Immunity 2002;16:673-83.
15. Gekas C, Dieterlen-Lievre F, Orkin SH, Mikkola HK. The placentais a niche for hematopoietic stem cells. Dev Cell 2005;8:365-75.
16. Ottersbach K, Dzierzak E. The murine placenta contains hema-topoietic stem cells within the vascular labyrinth region. Dev Cell 2005;8:377-87.
17. Johnson GR, Moore MA. Role of stem cell migration in initiationof mouse foetal liver haemopoiesis. Nature 1975;258:726-8.
18. Houssaint E. Differentiation of the mouse hepatic primordium. II.Extrinsic origin of the haemopoietic cell line. Cell Differ 1981; 10: 243-52.
19. Downs KM, Gifford S, Blahnik M, Gardner RL. Vascularization inthe murine allantois occurs by vasculogenesis without accompany-ing erythropoiesis. Development 1998;125:4507-20.
20. Kumaravelu P, Hook L, Morrison AM, Ure J, Zhao S, Zuyev S, etal. Quantitative developmental anatomy of definitive haema-topoietic stem cells/long-term repopulating units (HSC/RUs): roleof the aorta-gonad-mesonephros (AGM) region and the yolk sac incolonisation of the mouse embryonic liver. Development 2002; 129: 4891-9.
21. Takeuchi M, Sekiguchi T, Hara T, Kinoshita T, Miyajima A. Culti-vation of aorta-gonad-mesonephros-derived hematopoietic stemcells in the fetal liver microenvironment amplifies long-term re-populating activity and enhances engraftment to the bone marrow. Blood 2002;99:1190-6.
22. Ferkowicz MJ, Starr M, Xie X, Li W, Johnson SA, Shelley WC, etal. CD41 expression defines the onset of primitive and definitivehematopoiesis in the murine embryo. Development 2003;130:4393-403.
23. Palis J, Robertson S, Kennedy M, Wall C, Keller G. Developmentof erythroid and myeloid progenitors in the yolk sac and embryoproper of the mouse. Development 1999;126:5073-84.
24. Cumano A, Dieterlen-Lievre F, Godin I. Lymphoid potential,probed before circulation in mouse, is restricted to caudal intraem-bryonic splanchnopleura. Cell 1996;86:907-16.
25. Cumano A, Ferraz JC, Klaine M, Di Santo JP, Godin I. Intraem-bryonic, but not yolk sac hematopoietic precursors, isolated beforecirculation, provide long-term multilineage reconstitution. Immunity 2001;15:477-85.
26. Tavian M, Robin C, Coulombel L, Peault B. The human embryo,but not its yolk sac, generates lympho-myeloid stem cells: mappingmultipotent hematopoietic cell fate in intraembryonic mesoderm.Immunity 2001;15:487-95.
27. Murray P. The development in vitro of the blood of the early chickembryo. Proc Royal Soc london 1932;11:497-521.
28. Choi K, Kennedy M, Kazarov A, Papadimitriou JC, Keller G. Acommon precursor for hematopoietic and endothelial cells. Devel-opment 1998;125:725-32.
29. Fehling HJ, Lacaud G, Kubo A, Kennedy M, Robertson S, Keller G, et al. Tracking mesoderm induction and its specification to thehemangioblast during embryonic stem cell differentiation. Devel-opment 2003;130:4217-27.
30. Huber TL, Kouskoff V, Fehling HJ, Palis J, Keller G. Haeman-gioblast commitment is initiated in the primitive streak of themouse embryo. Nature 2004;432:625-30.
31. Ferkowicz MJ, Yoder MC. Blood island formation: longstandingobservations and modern interpretations. Exp Hematol 2005;33:1041-7.
32. Ueno H, Weissman IL. Clonal analysis of mouse developmentreveals a polyclonal origin for yolk sac blood islands. Dev Cell 2006; 11: 519-33.
33. North T, Gu TL, Stacy T, Wang Q, Howard L, Binder M, et al.Cbfa2 is required for the formation of intra-aortic hematopoieticclusters. Development 1999;126:2563-75.
34. Lancrin C, Sroczynska P, Stephenson C, Allen T, Kouskoff V,Lacaud G. The haemangioblast generates haematopoietic cellsthrough a haemogenic endothelium stage. Nature 2009;457:892-5.
35. Eilken HM, Nishikawa S, Schroeder T. Continuous single-cellimaging of blood generation from haemogenic endothelium. Nature 2009; 457: 896-900.
36. Chen MJ, Yokomizo T, Zeigler BM, Dzierzak E, Speck NA. Runx1 is required for the endothelial to haematopoietic cell transi-tion but not thereafter. Nature 2009;457:887-91.
37. Zovein AC, Hofmann JJ, Lynch M, French WJ, Turlo KA, Yang Y, et al. Fate tracing reveals the endothelial origin of hematopoieticstem cells. Cell Stem Cell 2008;3:625-36.
38. Bertrand JY, Giroux S, Golub R, Klaine M, Jalil A, Boucontet L, etal. Characterization of purified intraembryonic hematopoietic stemcells as a tool to define their site of origin. Proc Natl Acad Sci U SA 2005;102:134-9.
39. Rhodes KE, Gekas C, Wang Y, Lux CT, Francis CS, Chan DN, etal. The emergence of hematopoietic stem cells is initiated in theplacental vasculature in the absence of circulation. Cell Stem Cell 2008; 2: 252-63.
40. Robin C, Ottersbach K, Durand C, Peeters M, Vanes L, Tybule-wicz V, et al. An unexpected role for IL-3 in the embryonic devel-opment of hematopoietic stem cells. Dev Cell 2006;11:171-80.
41. Miura Y, Wilt FH. Tissue interaction and the formation of the firsterythroblasts of the chick embryo. Dev Biol 1969;19:201-11.
42. Pardanaud L, Dieterlen-Lievre F. Emergence of endothelial andhemopoietic cells in the avian embryo. Anat Embryol (Berl)1993;187:107-14.
43. Wilt FH. Erythropoiesis In The Chick Embryo: The Role Of Endo-derm. Science 1965;147:1588-1590.
44. Belaoussoff M, Farrington SM, Baron MH. Hematopoietic induc-tion and respecification of A-P identity by visceral endoderm sig-naling in the mouse embryo. Development 1998;125:5009-18.
45. Dyer MA, Farrington SM, Mohn D, Munday JR, Baron MH. Indianhedgehog activates hematopoiesis and vasculogenesis and can re-specify prospective neurectodermal cell fate in the mouse embryo. Development 2001;128:1717-30.
46. Pardanaud L, Dieterlen-Lievre F. Manipulation of the angio-poietic/hemangiopoietic commitment in the avian embryo. Devel-opment 1999;126:617-27.
47. Gering M, Patient R. Hedgehog signaling is required for adultblood stem cell formation in zebrafish embryos. Dev Cell 2005; 8: 389-400.
48. Faloon P, Arentson E, Kazarov A, Deng CX, Porcher C, Orkin S, etal. Basic fibroblast growth factor positively regulates hema-topoietic development. Development 2000;127:1931-41.
49. Shalaby F, Rossant J, Yamaguchi TP, Gertsenstein M, Wu XF, Breitman ML, et al. Failure of blood-island formation and vasculo-genesis in Flk-1-deficient mice. Nature 1995;376:62-6.
50. Winnier G, Blessing M, Labosky PA, Hogan BL. Bone morphoge-netic protein-4 is required for mesoderm formation and patterningin the mouse. Genes Dev 1995;9:2105-16.
51. Johansson BM, Wiles MV. Evidence for involvement of activin Aand bone morphogenetic protein 4 in mammalian mesoderm andhematopoietic development. Mol Cell Biol 1995;15:141-51.
52. Durand C, Robin C, Bollerot K, Baron MH, Ottersbach K, Dzier-zak E. Embryonic stromal clones reveal developmental regulatorsof definitive hematopoietic stem cells. Proc Natl Acad Sci U S A 2007; 104: 20838-43.
53. Kanatsu M, Nishikawa SI. In vitro analysis of epiblast tissue po-tency for hematopoietic cell differentiation. Development 1996; 122: 823-30.
54. Kumano K, Chiba S, Kunisato A, Sata M, Saito T, Nakagami-Yamaguchi E, et al. Notch1 but not Notch2 is essential for generat-ing hematopoietic stem cells from endothelial cells. Immunity 2003; 18: 699-711.
55. Robert-Moreno A, Espinosa L, de la Pompa JL, Bigas A.RBPjkappa-dependent Notch function regulates Gata2 and is essen-tial for the formation of intra-embryonic hematopoietic cells. De-velopment 2005;132:1117-26.
56. Minegishi N, Ohta J, Yamagiwa H, Suzuki N, Kawauchi S, Zhou Y, et al. The mouse GATA-2 gene is expressed in the para-aorticsplanchnopleura and aorta-gonads and mesonephros region. Blood 1999; 93: 4196-207.
57. Tsai FY, Keller G, Kuo FC, Weiss M, Chen J, Rosenblatt M, et al.An early haematopoietic defect in mice lacking the transcriptionfactor GATA-2. Nature 1994; 371: 221-6.
58. North TE, Goessling W, Walkley CR, Lengerke C, Kopani KR, Lord AM, et al. Prostaglandin E2 regulates vertebrate haema-topoietic stem cell homeostasis. Nature 2007; 447: 1007-11.
59. Bowie MB, McKnight KD, Kent DG, McCaffrey L, Hoodless PA, Eaves CJ. Hematopoietic stem cells proliferate until after birth andshow a reversible phase-specific engraftment defect. J Clin Invest 2006; 116: 2808-16.
60. Hock H, Hamblen MJ, Rooke HM, Schindler JW, Saleque S, Fuji-wara Y, et al. Gfi-1 restricts proliferation and preserves functionalintegrity of haematopoietic stem cells. Nature 2004;431:1002-7.
61. Hock H, Meade E, Medeiros S, Schindler JW, Valk PJ, Fujiwara Y, et al. Tel/Etv6 is an essential and selective regulator of adult hema-topoietic stem cell survival. Genes Dev 2004;18:2336-41.
62. Park IK, Qian D, Kiel M, Becker MW, Pihalja M, Weissman IL, etal. Bmi-1 is required for maintenance of adult self-renewing hae-matopoietic stem cells. Nature 2003; 423: 302-5.
63. Kim I, Saunders TL, Morrison SJ. Sox17 dependence distinguishesthe transcriptional regulation of fetal from adult hematopoietic stemcells. Cell 2007;130:470-83.
64. Mikkola HK, Orkin SH. The journey of developing hematopoieticstem cells. Development 2006; 133: 3733-44.
65. Martin MA, Bhatia M. Analysis of the human fetal liver hema-topoietic microenvironment. Stem Cells Dev 2005;14:493-504.
66. Stamatoyannopoulos G. Control of globin gene expression duringdevelopment and erythroid differentiation. Exp Hematol 2005;33:259-71.
67. Brotherton TW, Chui DH, Gauldie J, Patterson M. Hemoglobinontogeny during normal mouse fetal development. Proc Natl AcadSci U S A 1979;76:2853-7.
68. McGrath KE, Palis J. Hematopoiesis in the yolk sac: more thanmeets the eye. Exp Hematol 2005;33:1021-8.
69. Ikuta K, Kina T, MacNeil I, Uchida N, Peault B, Chien YH, et al.A developmental switch in thymic lymphocyte maturation potentialoccurs at the level of hematopoietic stem cells. Cell 1990;62:863-74.
70. Haas W, Pereira P, Tonegawa S. Gamma/delta cells. Annu RevImmunol 1993; 11: 637-85.
71. Ikuta K, Uchida N, Friedman J, Weissman IL. Lymphocyte devel-opment from stem cells. Annu Rev Immunol 1992;10:759-83.
72. Hardy RR, Hayakawa K. B cell development pathways. Annu RevImmunol 2001; 19: 595-621.
73. Hardy RR, Hayakawa K. A developmental switch in B lymphopoi-esis. Proc Natl Acad Sci U S A 1991;88:11550-4.
74. Carvalho TL, Mota-Santos T, Cumano A, Demengeot J, Vieira P. Arrested B lymphopoiesis and persistence of activated B cells inadult interleukin 7(-/)- mice. J Exp Med 2001;194:1141-50.
75. Adams GB, Scadden DT. The hematopoietic stem cell in its place. Nat Immunol 2006;7:333-7.
76. Kiel MJ, Morrison SJ. Uncertainty in the niches that maintain hae-matopoietic stem cells. Nat Rev Immunol 2008;8:290-301.
77. Brummendorf TH, Dragowska W, Zijlmans J, Thornbury G, Lans-dorp PM. Asymmetric cell divisions sustain long-term hematopoie-sis from single-sorted human fetal liver cells. J Exp Med 1998;188:1117-24.
78. Takano H, Ema H, Sudo K, Nakauchi H. Asymmetric division andlineage commitment at the level of hematopoietic stem cells: infer-ence from differentiation in daughter cell and granddaughter cellpairs. J Exp Med 2004;199:295-302.
79. Beckmann J, Scheitza S, Wernet P, Fischer JC, Giebel B. Asym-metric cell division within the human hematopoietic stem and pro-genitor cell compartment: identification of asymmetrically segre-gating proteins. Blood 2007;109:5494-501.
80. Krivtsov AV, Twomey D, Feng Z, Stubbs MC, Wang Y, Faber J, etal. Transformation from committed progenitor to leukaemia stemcell initiated by MLL-AF9. Nature 2006;442:818-22.
81. Varnum-Finney B, Xu L, Brashem-Stein C, Nourigat C, Flowers D, Bakkour S, et al. Pluripotent, cytokine-dependent, hematopoieticstem cells are immortalized by constitutive Notch1 signaling. NatMed 2000;6:1278-81.
82. Mancini SJ, Mantei N, Dumortier A, Suter U, MacDonald HR, Radtke F. Jagged1-dependent Notch signaling is dispensable forhematopoietic stem cell self-renewal and differentiation. Blood 2005;105:2340-2.
83. Congdon KL, Voermans C, Ferguson EC, DiMascio LN, Uqoezwa M, Zhao C, et al. Activation of Wnt signaling in hematopoietic re-generation. Stem Cells 2008;26:1202-10.
84. Mikkola HK, Klintman J, Yang H, Hock H, Schlaeger TM, Fuji-wara Y, et al. Haematopoietic stem cells retain long-term repopu-lating activity and multipotency in the absence of stem-cell leu-kaemia SCL/tal-1 gene. Nature 2003;421:547-51.
85. Kotake Y, Cao R, Viatour P, Sage J, Zhang Y, Xiong Y. pRB fam-ily proteins are required for H3K27 trimethylation and Polycombrepression complexes binding to and silencing p16INK4alpha tu-mor suppressor gene. Genes Dev 2007;21:49-54.
86. Bracken AP, Kleine-Kohlbrecher D, Dietrich N, Pasini D, Gargiulo G, Beekman C, et al. The Polycomb group proteins bind through-out the INK4A-ARF locus and are disassociated in senescent cells. Genes Dev 2007;21:525-30.
87. Reya T, Duncan AW, Ailles L, Domen J, Scherer DC, Willert K, etal. A role for Wnt signalling in self-renewal of haematopoieticstem cells. Nature 2003;423:409-14.
88. Zhang CC, Kaba M, Ge G, Xie K, Tong W, Hug C, et al. Angio-poietin-like proteins stimulate ex vivo expansion of hematopoieticstem cells. Nat Med 2006;12:240-5.
89. Sauvageau G, Thorsteinsdottir U, Eaves CJ, Lawrence HJ, Larg-man C, Lansdorp PM, et al. Overexpression of HOXB4 in hema-topoietic cells causes the selective expansion of more primitivepopulations in vitro and in vivo. Genes Dev 1995;9:1753-17565.
90. Thorsteinsdottir U, Mamo A, Kroon E, Jerome L, Bijl J, Lawrence HJ, et al. Overexpression of the myeloid leukemia-associatedHoxa9 gene in bone marrow cells induces stem cell expansion.Blood 2002;99:121-9.
91. Nerlov C, Graf T. PU.1 induces myeloid lineage commitment inmultipotent hematopoietic progenitors. Genes Dev 1998;12:2403-12.
92. Rodrigues NP, Janzen V, Forkert R, Dombkowski DM, Boyd AS, Orkin SH, et al. Haploin sufficiency of GATA-2 perturbs adult he-matopoietic stem-cell homeostasis. Blood 2005;106:477-84.
93. Zeng H, Yucel R, Kosan C, Klein-Hitpass L, Moroy T. Transcrip-tion factor Gfi1 regulates self-renewal and engraftment of hema-topoietic stem cells. Embo J 2004;23:4116-25.
94. Wilson A, Murphy MJ, Oskarsson T, Kaloulis K, Bettess MD, Oser GM, et al. c-Myc controls the balance between hematopoietic stemcell self-renewal and differentiation. Genes Dev 2004;18:2747-63.
95. Karlsson G, Blank U, Moody JL, Ehinger M, Singbrant S, Deng CX, et al. Smad4 is critical for self-renewal of hematopoietic stemcells. J Exp Med 2007;204:467-74.
96. Asahara T, Masuda H, Takahashi T, Kalka C, Pastore C, Silver M, et al. Bone marrow origin of endothelial progenitor cells responsi-ble for postnatal vasculogenesis in physiological and pathologicalneovascularization. Circ Res 1999;85:221-8.
97. Mezey E, Chandross KJ, Harta G, Maki RA, McKercher SR. Turn-ing blood into brain: cells bearing neuronal antigens generated invivo from bone marrow. Science 2000;290:1779-82.
98. Brazelton TR, Rossi FM, Keshet GI, Blau HM. From marrow tobrain: expression of neuronal phenotypes in adult mice. Science 2000; 290: 1775-9.
99. Eglitis MA, Mezey E. Hematopoietic cells differentiate into bothmicroglia and macroglia in the brains of adult mice. Proc Natl AcadSci U S A 1997;94:4080-5.
100. Alison MR, Poulsom R, Jeffery R, Dhillon AP, Quaglia A, Jacob J, et al. Hepatocytes from non-hepatic adult stem cells. Nature 2000; 406: 257.
101. Petersen BE, Bowen WC, Patrene KD, Mars WM, Sullivan AK, Murase N, et al. Bone marrow as a potential source of hepatic ovalcells. Science 1999;284:1168-70.
102. Ferrari G, Cusella-De Angelis G, Coletta M, Paolucci E, Stornai-uolo A, Cossu G, et al. Muscle regeneration by bone marrow-derived myogenic progenitors. Science 1998;279:1528-30.
103. Bittner RE, Schofer C, Weipoltshammer K, Ivanova S, Streubel B, Hauser E, et al. Recruitment of bone-marrow-derived cells byskeletal and cardiac muscle in adult dystrophic mdx mice. AnatEmbryol (Berl) 1999;199:391-396.
104. Gussoni E, Soneoka Y, Strickland CD, Buzney EA, Khan MK, Flint AF, et al. Dystrophin expression in the mdx mouse restoredby stem cell transplantation. Nature 1999;401:390-4.
105. Orlic D, Kajstura J, Chimenti S, Bodine DM, Leri A, Anversa P.Transplanted adult bone marrow cells repair myocardial infarcts inmice. Ann N Y Acad Sci 2001; 938: 221-9; discussion 9-30.
106. Peault B, Oberlin E, Tavian M. Emergence of hematopoietic stemcells in the human embryo. C R Biol 2002;325:1021-6.
107. Vaziri H, Dragowska W, Allsopp RC, Thomas TE, Harley CB, Lansdorp PM. Evidence for a mitotic clock in human hema-topoietic stem cells: loss of telomeric DNA with age. Proc NatlAcad Sci U S A 1994;91:9857-60.
108. Morrison SJ, Weissman IL. The long-term repopulating subset ofhematopoietic stem cells is deterministic and isolatable by pheno-type. Immunity 1994;1:661-73.
109. Christensen JL, Weissman IL. Flk-2 is a marker in hematopoieticstem cell differentiation: a simple method to isolate long-term stemcells. Proc Natl Acad Sci U S A 2001;98:14541-6.
110. Osawa M, Hanada K, Hamada H, Nakauchi H. Long-term lympho-hematopoietic reconstitution by a single CD34-low/negative hema-topoietic stem cell. Science 1996;273:242-5.
111. Akashi K, Traver D, Miyamoto T, Weissman IL. A clonogeniccommon myeloid progenitor that gives rise to all myeloid lineages.Nature 2000;404:193-7.
112. Serwold T, Ehrlich LI, Weissman IL. Reductive isolation frombone marrow and blood implicates common lymphoid progenitorsas the major source of thymopoiesis. Blood 2009;113:807-15.
113. Karsunky H, Inlay MA, Serwold T, Bhattacharya D, Weissman IL. Flk2+ common lymphoid progenitors possess equivalent differen-tiation potential for the B and T lineages. Blood 2008;111:5562-70.
114. Kondo M, Weissman IL, Akashi K. Identification of clonogeniccommon lymphoid progenitors in mouse bone marrow. Cell1 1997; 91:661-72.
115. Na Nakorn T, Traver D, Weissman IL, Akashi K. Myeloerythroid-restricted progenitors are sufficient to confer radioprotection andprovide the majority of day 8 CFU-S. J Clin Invest 2002;109:1579-85.
116. Pronk CJ, Rossi DJ, Mansson R, Attema JL, Norddahl GL, Chan CK, et al. Elucidation of the phenotypic, functional, and moleculartopography of a myeloerythroid progenitor cell hierarchy. CellStem Cell 2007;1:428-42.
117. Chen CC, Grimbaldeston MA, Tsai M, Weissman IL, Galli SJ. Identification of mast cell progenitors in adult mice. Proc NatlAcad Sci U S A 2005;102:11408-13.
118. Traver D, Akashi K, Manz M, Merad M, Miyamoto T, Engleman EG, et al. Development of CD8alpha-positive dendritic cells from acommon myeloid progenitor. Science 2000;290:2152-4.
119. Manz MG, Traver D, Miyamoto T, Weissman IL, Akashi K. Den-dritic cell potentials of early lymphoid and myeloid progenitors. Blood 2001;97:3333-41.
120. Adolfsson J, Mansson R, Buza-Vidas N, Hultquist A, Liuba K, Jensen CT, et al. Identification of Flt3+ lympho-myeloid stem cellslacking erythro-megakaryocytic potential a revised road map foradult blood lineage commitment. Cell 2005;121:295-306.
121. Arinobu Y, Mizuno S, Chong Y, Shigematsu H, Iino T, Iwasaki H, et al. Reciprocal activation of GATA-1 and PU.1 marks initialspecification of hematopoietic stem cells into myeloerythroid andmyelolymphoid lineages. Cell Stem Cell 2007;1:416-27.
122. Lai AY, Kondo M. Asymmetrical lymphoid and myeloid lineagecommitment in multipotent hematopoietic progenitors. J Exp Med 2006; 203: 1867-73.
123. Hao QL, Zhu J, Price MA, Payne KJ, Barsky LW, Crooks GM. Identification of a novel, human multilymphoid progenitor in cordblood. Blood 2001;97:3683-90.
124. Hoebeke I, De Smedt M, Stolz F, Pike-Overzet K, Staal FJ, Plum J,et al. T-, B- and NK-lymphoid, but not myeloid cells arise fromhuman CD34(+)CD38(-)CD7(+) common lymphoid progenitorsexpressing lymphoid-specific genes. Leukemia 2007;21:311-9.
125. Six EM, Bonhomme D, Monteiro M, Beldjord K, Jurkowska M,Cordier-Garcia C, et al. A human postnatal lymphoid progenitorcapable of circulating and seeding the thymus. J Exp Med 2007; 204: 3085-93.
126. Doulatov S, Notta F, Eppert K, Nguyen LT, Ohashi PS, Dick JE.Revised map of the human progenitor hierarchy shows the origin ofmacrophages and dendritic cells in early lymphoid development.Nat Immunol; 11: 585-93.
127. Yoshida T, Ng SY, Zuniga-Pflucker JC, Georgopoulos K. Earlyhematopoietic lineage restrictions directed by Ikaros. Nat Immunol2006;7:382-91.
128. Kastner P, Lawrence HJ, Waltzinger C, Ghyselinck NB, ChambonP, Chan S. Positive and negative regulation of granulopoiesis byendogenous RARalpha. Blood 2001;97:1314-20.
129. Taschner S, Koesters C, Platzer B, Jorgl A, Ellmeier W, Benesch T, et al. Down-regulation of RXRalpha expression is essential forneutrophil development from granulocyte/monocyte progenitors.Blood 2007;109:971-9.
130. Iwasaki H, Mizuno S, Wells RA, Cantor AB, Watanabe S, Akashi K. GATA-1 converts lymphoid and myelomonocytic progenitorsinto the megakaryocyte/erythrocyte lineages. Immunity 2003;19:451-62.
131. Dahl R, Walsh JC, Lancki D, Laslo P, Iyer SR, Singh H, et al.Regulation of macrophage and neutrophil cell fates by thePU.1:C/EBPalpha ratio and granulocyte colony-stimulating factor. Nat Immunol 2003;4:1029-36.
132. Bjornson CR, Rietze RL, Reynolds BA, Magli MC, Vescovi AL. Turning brain into blood: a hematopoietic fate adopted by adultneural stem cells in vivo. Science 1999;283:534-7.
133. Eglitis MA, Dawson D, Park KW, Mouradian MM. Targeting of marrow-derived astrocytes to the ischemic brain. Neuroreport 1999;10:1289-92.
134. Woodbury D, Schwarz EJ, Prockop DJ, Black IB. Adult rat andhuman bone marrow stromal cells differentiate into neurons. J Neu-rosci Res 2000;61:364-70.
135. Cogle CR, Yachnis AT, Laywell ED, Zander DS, Wingard JR, Steindler DA, et al. Bone marrow transdifferentiation in brain aftertransplantation: a retrospective study. Lancet 2004;363:1432-7.
136. Crain BJ, Tran SD, Mezey E. Transplanted human bone marrowcells generate new brain cells. J Neurol Sci 2005;233:121-3.
137. Anderson DJ, Gage FH, Weissman IL. Can stem cells cross lineageboundaries? Nat Med 2001;7:393-5.
138. Alvarez-Dolado M, Pardal R, Garcia-Verdugo JM, Fike JR, Lee HO, Pfeffer K, et al. Fusion of bone-marrow-derived cells withPurkinje neurons, cardiomyocytes and hepatocytes. Nature 2003;425:968-73.
139. Weimann JM, Charlton CA, Brazelton TR, Hackman RC, Blau HM. Contribution of transplanted bone marrow cells to Purkinjeneurons in human adult brains. Proc Natl Acad Sci U S A 2003; 100: 2088-93.
140. Weimann JM, Johansson CB, Trejo A, Blau HM. Stable repro-grammed heterokaryons form spontaneously in Purkinje neuronsafter bone marrow transplant. Nat Cell Biol 2003;5:959-66.
141. Lagasse E, Connors H, Al-Dhalimy M, Reitsma M, Dohse M,Osborne L, et al. Purified hematopoietic stem cells can differentiateinto hepatocytes in vivo. Nat Med 2000;6:1229-34.
142. Grompe M. The role of bone marrow stem cells in liver regenera-tion. Semin Liver Dis 2003;23:363-72.
143. Theise ND, Nimmakayalu M, Gardner R, Illei PB, Morgan G, Teperman L, et al. Liver from bone marrow in humans. Hepatology 2000; 32: 11-6.
144. Korbling M, Katz RL, Khanna A, Ruifrok AC, Rondon G, Albitar M, et al. Hepatocytes and epithelial cells of donor origin in recipi-ents of peripheral-blood stem cells. N Engl J Med 2002;346:738-46.
145. Stamm C, Westphal B, Kleine HD, Petzsch M, Kittner C, Klinge H, et al. Autologous bone-marrow stem-cell transplantation formyocardial regeneration. Lancet 2003;361:45-6.
146. Tse HF, Kwong YL, Chan JK, Lo G, Ho CL, Lau CP. Angiogene-sis in ischaemic myocardium by intramyocardial autologous bonemarrow mononuclear cell implantation. Lancet 2003;361:47-9.
147. Mathur A, Martin JF. Stem cells and repair of the heart. Lancet 2004; 364: 183-92.
148. Wollert KC, Meyer GP, Lotz J, Ringes-Lichtenberg S, Lippolt P, Breidenbach C, et al. Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised con-trolled clinical trial. Lancet 2004;364:141-8.
149. Griesel C, Heuft HG, Herrmann D, Franke A, Ladas D, Stiehler N, et al. Good manufacturing practice-compliant validation and prepa-ration of BM cells for the therapy of acute myocardial infarction.Cytotherapy 2007;9:35-43.
150. Borue X, Lee S, Grove J, Herzog EL, Harris R, Diflo T, et al. Bonemarrow-derived cells contribute to epithelial engraftment duringwound healing. Am J Pathol 2004;165:1767-72.
151. Jiang S, Walker L, Afentoulis M, Anderson DA, Jauron-Mills L, Corless CL, et al. Transplanted human bone marrow contributes tovascular endothelium. Proc Natl Acad Sci U S A 2004;101:16891-6.
152. Murata H, Janin A, Leboeuf C, Soulier J, Gluckman E, Meignin V, et al. Donor-derived cells and human graft-versus-host disease ofthe skin. Blood 2007;109:2663-5.
153. Suzuki T, Nishida M, Futami S, Fukino K, Amaki T, Aizawa K, etal. Neoendothelialization after peripheral blood stem cell transplan-tation in humans: a case report of a Tokaimura nuclear accidentvictim. Cardiovasc Res 2003;58:487-92.
154. Visconti RP, Ebihara Y, LaRue AC, Fleming PA, McQuinn TC, Masuya M, et al. An in vivo analysis of hematopoietic stem cell po-tential: hematopoietic origin of cardiac valve interstitial cells. CircRes 2006;98:690-6.
155. Wylie-Sears J, Aikawa E, Levine RA, Yang JH, Bischoff J. Mitralvalve endothelial cells with osteogenic differentiation potential. Ar-terioscler Thromb Vasc Biol; 31: 598-607.
156. Mooney JE, Rolfe BE, Osborne GW, Sester DP, van Rooijen N, Campbell GR, et al. Cellular plasticity of inflammatory myeloidcells in the peritoneal foreign body response. Am J Pathol; 176: 369-80.
157. Medvinsky A, Smith A. Stem cells: Fusion brings down barriers. Nature 2003;422:823-5.
158. Bryder D, Rossi DJ, Weissman IL. Hematopoietic stem cells: theparadigmatic tissue-specific stem cell. Am J Pathol 2006;169:338-46.
159. Ringden O, Remberger M, Svenberg P, Svahn BM, Dahllof G, Gustafsson B, et al. Fludarabine-based disease-specific condition-ing or conventional myeloablative conditioning in hematopoieticstem cell transplantation for treatment of non-malignant diseases. Bone Marrow Transplant 2007;39:383-8.
160. Petit I, Szyper-Kravitz M, Nagler A, Lahav M, Peled A, Habler L, et al. G-CSF induces stem cell mobilization by decreasing bonemarrow SDF-1 and up-regulating CXCR4. Nat Immunol 2002; 3: 687-94.
161. De Clercq E. Potential clinical applications of the CXCR4 antago-nist bicyclam AMD3100. Mini Rev Med Chem 2005;5:805-24.
162. Brunstein CG, Setubal DC, Wagner JE. Expanding the role ofumbilical cord blood transplantation. Br J Haematol 2007;137:20-35.
163. Weiss ML, Troyer DL. Stem cells in the umbilical cord. Stem CellRev 2006;2:155-62.
164. Ballen KK, Spitzer TR, Yeap BY, McAfee S, Dey BR, Attar E, etal. Double unrelated reduced-intensity umbilical cord blood trans-plantation in adults. Biol Blood Marrow Transplant 2007;13:82-9.
165. Sorrentino BP. Clinical strategies for expansion of haematopoieticstem cells. Nat Rev Immunol 2004;4:878-88.
166. Hale GA. Autologous hematopoietic stem cell transplantation forpediatric solid tumors. Expert Rev Anticancer Ther 2005;5:835-46.
167. George RE, Li S, Medeiros-Nancarrow C, Neuberg D, Marcus K, Shamberger RC, et al. High-risk neuroblastoma treated with tan-dem autologous peripheral-blood stem cell-supported transplanta-tion: long-term survival update. J Clin Oncol 2006;24:2891-6.
168. Frickhofen N, Berdel WE, Opri F, Haas R, Schneeweiss A, Sand-herr M, et al. Phase I/II trial of multicycle high-dose chemotherapywith peripheral blood stem cell support for treatment of advancedovarian cancer. Bone Marrow Transplant 2006;38:493-9.
169. Barfield RC, Hale GA, Burnette K, Behm FG, Knapp K, Eldridge P, et al. Autologous transplantation of CD133 selected hema-topoietic progenitor cells for treatment of relapsed acute lym-phoblastic leukemia. Pediatr Blood Cancer 2007;48:349-53.
170. Oyan B, Koc Y, Kansu E. Successful salvage with high-dose se-quential chemotherapy coupled with in vivo purging and autolo-gous stem cell transplantation in 2 patients with primary refractorymantle cell lymphoma presenting in the leukemic phase. Int J He-matol 2005;81:155-8.
171. Krause DS, Lazarides K, von Andrian UH, Van Etten RA. Re-quirement for CD44 in homing and engraftment of BCR-ABL-expressing leukemic stem cells. Nat Med 2006;12:1175-80.
172. McSweeney PA, Storb R. Mixed chimerism: preclinical studies andclinical applications. Biol Blood Marrow Transplant 1999;5:192-203.
173. Tyndall A, Koike T. High-dose immunoablative therapy with he-matopoietic stem cell support in the treatment of severe autoim-mune disease: current status and future direction. Intern Med 2002; 41: 608-12.
174. Burt RK, Slavin S, Burns WH, Marmont AM. Induction of toler-ance in autoimmune diseases by hematopoietic stem cell transplan-tation: getting closer to a cure? Blood 2002;99:768-84.
175. Ikehara S. Treatment of autoimmune diseases by hematopoieticstem cell transplantation. Exp Hematol 2001;29:661-9.
176. van Bekkum DW. Experimental basis of hematopoietic stem celltransplantation for treatment of autoimmune diseases. J LeukocBiol 2002;72:609-20.
177. Marmont AM. Stem cell transplantation for severe autoimmunedisorders, with special reference to rheumatic diseases. J Rheuma-tol Suppl 1997;48:13-8.
178. Yin AH, Miraglia, S., Godfry, W. G., Buck, D.W. Human hema-topoietic stem and progenitor cell antigen. US 6,455,678 (2002).
179. Lemischka IR. Nucleic acids encoding hematopoietic stem cellsreceptors Flk-1. US 5,283,354 (1994).
180. Nilsson SK, Simmons, P.J., Haylock, D.N. Identifying hema-topoietic stem cells based on cell surface markers. US 7, 718, 379(2010).
181. Moon RT, Bhatia, M., Trowbridge, J. Methods for regulation ofstem cells. US 7,850,960 (2010).
182. McGlave PB, Verfaillie, C.M. Stroma-derived proteoglycan con-taining composition which promotes differentiation and maintainsthe self-renewal capacity of long-term bone-marrow culture-initiationg cells. US 5,523,286 (1996).
183. Peled T, Fibach, E., Tresves,A. Method of controlling proliferationand differentiation stem and progenitor cells. US 6,887,704 (2005).
184. Beug H, Wessely, O., Steinlein, P., Deiner, E., Von Lindern, M.M. Process for preparing and cultivating hematopoietic progenitorcells. US 5,905,041 (1999).
185. Matthews W, Austin, T.W. Method of enhancing proliferation ordifferentiation of hematopoietic stem cells using Wnt polypeptide.US 5,851,984 (1998).
186. Verfaillie C, Schoemans, H., Snoeckx, R. HSC self-renewal. WO2010052580 (2010).
187. Scadden D, Guo, S., Lu, J. Method for MIR-125A in promotinghematopoietic stem cell self renewal and expansion.WO2010017551 (2010).
188. Klug CA. Regulation of self-renewal in stem cells. WO04085616(2004).
189. Zon LI, North, T. E., Goessling, W. Method to modulate hema-topoietic stem cell growth. 20090285786 (2009).
190. Witte L, Pytowski, B., Moore, K. A., Lemischka, I. R. Use of delta-like protein to inhibit the differentiation of stem cells. US6,613,565 (2003).
191. Krause M, Deng, H., Liu, L. Modulation of primary stem cell dif-ferentiation using an insulin-like growth factor binding protein. US6,841,386 (2005).
192. Li L, Hood, L. Human jagged polypeptide,encoding nucleic acidsand methods of use. US 6,136,952 (2000).
193. Rodgers K, diZerega, G. Methods of promoting hematopoietic andmesenchymal cell proliferation and differentiation. US 7,744,927(2010).
194. + progenitor cells into T lymphocytes. US 5,677,139(1997).
195. Tsai S, Collins, S. J. Creating novel hematopoietic cell lines byexpressing altered retinoic acid receptors. US 5,830,760 (1998).
196. Besmer P, Buck, J., Moore, M. A. S., Nocka, K. Use of c-kit ligandwith TNF- and hematopoietic factors for the expansion and differ-entiation of hematopoietic cells. US 6,159,461 (2000).
197. Kirsch IR, Begley, C. G. SCL: a hematopoietic growth and differ-entiation factor. US 5,214,133 (1993).
198. Largman C, Lawrence, H. J., Humphries, R. K., Sauvageau, G.Hox-induced enhancement of in vivo and in vitro proliferative ca-pacity and gene therapeutic methods. US 5,837,507 (1998).
199. Bjornson CR, Rietze, R. L., Reynolds, B. A., Vescovi, A.L. Gen-eration of hematopoietic cells from multipotent neural stem cells.US 6,093,531 (2000).
200. Jurecic R, Nachtman, R. G. Hepp, a novel gene with a role in he-matopoietic and neural development. US 6,872,812 (2005).
201. Tsukamoto A, Baum, C. M., Aihara, Y., Weissman, I. Humanhematopoietic stem cell. US 5,750,397 (1998).
202. Ildstad ST. Methods for enhancing engraftment of purified hema-topoietic stem cells in allogeneic recipients. US20060140912(2006).
203. Ildstad ST. Methods for enhancing engraftment of purified hema-topoietic stem cells in allogeneic recipients. US20070098693(2007).
204. Boyse EA, Broxmeyer, H. E., Douglas, G. W. Isolation and preser-vation of fetal and neonatal hematopoietic stem and progenitorcells of the blood and methods of therapeutic use. US 5,192,553(1993).
205. Waller EK. Method of allogeneic hematopoietic stem cell trans-plantation without graft failure or graft vs host disease. US5,800,539 (1998).
206. Slavin S. Allogeneic cell therapy for cancer following allogeneicstem cell transplantation. US 6,143,292 (2000).
207. Friedlander M, Otani, A., Silva, K. D., Moreno S. Isolated lineagenegative hematopoietic stem cells and methods of treatment there-with. US20050129665 (2005).
208. Li H, Lee, Y. J. Treating retinal degeneration caused by retinal veinocclusion or retinal ischemia. US 7,645,447 (2010).